Antengene Corporation Limited (722.F)
Antengene Corporation Limited, a clinical-stage APAC biopharmaceutical company, develops novel oncology therapies in Greater China and internationally.
0.41+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-19.6%
The outlook
Antengene Corporation Limited currently reads as leaning bearish based on mixed vs its moving averages, 23% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range23% of the way from its 52-week low to high
Market cap
$280.5M
52-wk high
0.85
52-wk low
0.29
50-day avg
0.41
200-day avg
0.45
Trailing P/E
—